Mingchen Health Co.,Ltd. (SHE:002919)
China · Delayed Price · Currency is CNY 26.05
-0.10 (-0.38%)
At close: Feb 6, 2026
Mingchen Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,470 | 1,376 | 1,634 | 944.04 | 743.07 | 677.12 |
Other Revenue | 4.29 | 4.29 | 3.38 | 1.37 | 1.08 | 3.45 |
| 1,474 | 1,380 | 1,638 | 945.4 | 744.15 | 680.57 | |
Revenue Growth (YoY) | 11.78% | -15.71% | 73.21% | 27.05% | 9.34% | 31.52% |
Cost of Revenue | 791.71 | 665.8 | 660.08 | 457.7 | 378.28 | 407.98 |
Gross Profit | 682.72 | 714.45 | 977.49 | 487.71 | 365.87 | 272.59 |
Selling, General & Admin | 609.57 | 548.57 | 777.45 | 400.32 | 152.59 | 124.6 |
Research & Development | 58.97 | 67.38 | 106.77 | 110.26 | 98.51 | 46.27 |
Other Operating Expenses | 4.82 | 5.15 | 4.71 | 5.36 | 6.57 | 6.35 |
Operating Expenses | 709.59 | 670.8 | 903.25 | 507.77 | 264.18 | 178.28 |
Operating Income | -26.87 | 43.65 | 74.24 | -20.06 | 101.69 | 94.31 |
Interest Expense | -1.3 | -1.58 | -3.68 | -1.95 | -1.71 | -2.16 |
Interest & Investment Income | 0.95 | 1.2 | 1.15 | 6.76 | 25.21 | 9.29 |
Currency Exchange Gain (Loss) | 0.98 | 0.98 | 1.76 | 0.99 | - | - |
Other Non Operating Income (Expenses) | 1.41 | -0.51 | 0.69 | -1.28 | -2.5 | -0.14 |
EBT Excluding Unusual Items | -24.83 | 43.74 | 74.16 | -15.54 | 122.69 | 101.3 |
Impairment of Goodwill | - | - | -23.54 | - | - | - |
Gain (Loss) on Sale of Investments | 0.69 | 0.38 | - | -0 | 0 | 0.55 |
Gain (Loss) on Sale of Assets | 0.84 | 4.38 | 2.07 | 0.1 | -0.01 | - |
Asset Writedown | -15.01 | -17.37 | -0.02 | -0.05 | -0.12 | -0.63 |
Other Unusual Items | -3.17 | -3.65 | 3.97 | 30.75 | 4.94 | 3.54 |
Pretax Income | -41.47 | 27.48 | 56.63 | 15.25 | 127.51 | 104.76 |
Income Tax Expense | -33.8 | -19.24 | -13.73 | -10.14 | -5.99 | 2.52 |
Earnings From Continuing Operations | -7.67 | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 |
Minority Interest in Earnings | 0.16 | 0 | - | - | - | - |
Net Income | -7.51 | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 |
Net Income to Common | -7.51 | 46.72 | 70.36 | 25.39 | 133.49 | 102.24 |
Net Income Growth | - | -33.60% | 177.15% | -80.98% | 30.57% | 343.05% |
Shares Outstanding (Basic) | 260 | 260 | 271 | 277 | 267 | 266 |
Shares Outstanding (Diluted) | 260 | 260 | 271 | 277 | 267 | 266 |
Shares Change (YoY) | -3.81% | -4.09% | -2.25% | 3.70% | 0.43% | 0.22% |
EPS (Basic) | -0.03 | 0.18 | 0.26 | 0.09 | 0.50 | 0.38 |
EPS (Diluted) | -0.03 | 0.18 | 0.26 | 0.09 | 0.50 | 0.38 |
EPS Growth | - | -30.77% | 183.53% | -81.66% | 30.00% | 342.07% |
Free Cash Flow | 43.69 | 116.66 | 56.61 | -77.28 | 64.4 | 157.05 |
Free Cash Flow Per Share | 0.17 | 0.45 | 0.21 | -0.28 | 0.24 | 0.59 |
Dividend Per Share | 0.050 | 0.050 | 0.125 | - | 0.137 | 0.117 |
Dividend Growth | -60.00% | -60.00% | - | - | 17.64% | 155.02% |
Gross Margin | 46.30% | 51.76% | 59.69% | 51.59% | 49.17% | 40.05% |
Operating Margin | -1.82% | 3.16% | 4.53% | -2.12% | 13.66% | 13.86% |
Profit Margin | -0.51% | 3.38% | 4.30% | 2.69% | 17.94% | 15.02% |
Free Cash Flow Margin | 2.96% | 8.45% | 3.46% | -8.18% | 8.65% | 23.08% |
EBITDA | -86.54 | 71.82 | 219.53 | 17.11 | 119.69 | 106.75 |
EBITDA Margin | -5.87% | 5.20% | 13.41% | 1.81% | 16.08% | 15.68% |
D&A For EBITDA | -59.67 | 28.17 | 145.29 | 37.16 | 18.01 | 12.44 |
EBIT | -26.87 | 43.65 | 74.24 | -20.06 | 101.69 | 94.31 |
EBIT Margin | -1.82% | 3.16% | 4.53% | -2.12% | 13.66% | 13.86% |
Effective Tax Rate | - | - | - | - | - | 2.41% |
Revenue as Reported | 1,474 | 1,380 | 1,638 | 945.4 | 744.15 | 680.57 |
Advertising Expenses | - | 8.32 | 6.73 | 4.16 | 5.61 | 5.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.